Vortex Web Site
of the Dialysis World

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Endosafe® - PTS™ from Charles River – Real-time endotoxin analysis for rapid release testing of dialysis samples.
B Braun's Dialog™ sets new standards for safety, efficiency and reliability.

Reduce Reuse Recycle, It's That Simple Medivators.

American Renal Associates offers big company experience and small company responsiveness. Let us help you open a new dialysis facility.
Daily Highlights
Company of the Day: RPC
Since January 1999, RenalWEB has been the premier Internet location for information on dialysis-related products and services. Features include:
Dialysis Yellow Pages
  Dialysis Product Showcase
  Recent Daily Highlights
View the Latest Feature Ads

Nipro -
Hi Flux Dialyzers

B. Braun -
Water Treatment

Better Water -
Concentrate Mixing Systems

American Renal Associates -
Provider / Management

Diasol -

NxStage -
Home Hemodialysis

Myron L -
Dialysate Meters

Asahi -
High Flux Dialyzers
Advertising Opportunities
  July 28, 2016
Scientists Change Properties of Zeolites to Improve Hemodialysis
Press release from National Research Tomsk State University (Russia).
One Hour of Physical Activity per Day Could Offset Health Risk of 8 Hours of Sitting
Press release and abstract (full-text free with registration) from The Lancet. Article from HealthDay.
Free, Full-Text, August 2016 Issue of Clinical Kidney Journal
23 full-text articles including:
Hospitalization Rates for Patients on Assisted Peritoneal Dialysis Compared with In-Center Hemodialysis
CJASN Express abstract.
Non-Invasive Approaches in the Diagnosis of Acute Rejection in Kidney Transplant Recipients. Part I. In vivo Imaging Methods
Free, full-text, Advance Access article from Clinical Kidney Journal.

Intravenous Vitamin B6 Increases Resistance to Erythropoiesis-Stimulating Agents in Hemodialysis Patients: A Randomized Controlled Trial
Article in Press abstract from Journal of Renal Nutrition.

Echo Color Doppler Ultrasound: a Valuable Diagnostic Tool in the Assessment of Arteriovenous Fistula in Hemodialysis Patients
Advance Online abstract from the Journal of Vascular Access.
A Novel Factor for Primary Arteriovenous Fistula Failure: Hyperinsulinism
Abstract from Renal Failure.
Cardiac and Renovascular Complications in Type 2 Diabetes — Is There Hope?
Free, full-text, editorial and related full-text article and abstract from the New England Journal of Medicine.
The Dialysis Industry Is a Microcosm of What Ails the Health Care System
Posting from the KevinMD blog.

Editor's note: This explains only a small portion of what is wrong with the U.S. dialysis industry.

Dialysis patients with private insurance automatically convert to the Medicare rate after 33 months, so there is no financial incentive to increase long-term survival. Over the last several decades, a large percentage of U.S. nephrologists greatly profited from the rise of the duopoly of Fresenius and DaVita, selling their dialysis patients/facilities to these companies, which utilized junk-bond financing for these purchases. For most patients, this led to minimal, standardized care (cheapest possible dialysis) that focused on meeting biochemical marker targets, which some have alleged have been the source of widespread fraud. Dialysis patient employment and rehabilitation, which drove rapid technological innovations in the 1960s, were abandoned by nephrologists after the government began paying for dialysis in 1973.

As a result, U.S. dialysis care has lagged far behind all other fields of medicine in terms of advances in survival and technology. When asked, virtually all U.S. nephrologists state they would avoid the treatment regimens that the vast majority of their patients receive. More than any other medical specialty, U.S. dialysis care has tied its practice of medicine to the servicing of junk-bond debt.
Baxter Touts Study Indicating Cost Savings with Revaclear Dialyzer
Amgen 2nd-Quarter Profit Tops Street View, Raises 2016 Forecast
American Renal Associates Holdings, Inc. Opens Its 200th Dialysis Clinic
Study Suggests New Drug Candidate Could Treat Both Type 2 Diabetes and Bone Loss
Lack of Exercise Costs World $67.5 Billion and 5 Million Lives a Year
Article from Reuters. Abstract (full-text free with registration) from The Lancet.
Infectious Disease Expert Sees Threat From Colistin-Resistant Superbug
Free, full-text, Online First perspective piece from the Journal of the American Medical Association.
Emisoft Unveils Free Ransomware Decryptor to Unlock Your Own Data
Article from Healthcare IT News.
CMS Releases Controversial Overall Star Ratings on Hospital Quality
Articles from Healthcare Finance and Kaiser Health News. Fact sheet from CMS.

Previous News Stories
Why U.S. Dialysis Care Has Been Stagnant
Understanding Tassin
Nephrologists Can't Have It Both Ways (2015)
Ten Issues Nephrologists Do Not Want To Discuss with Dialysis Patients (2014)
The Missing Half of Excellence in
Dialysis Care 2013)
Human-Centered Care (2013)
Fix Dialysis
Boston ESRD Conference (2009)
New Views (2008)
Discussion Boards
Classified Ads
Dialysis Topics: Internet Resources

Read Legal Disclaimer

Copyright© 2016 RenalWEB. All rights reserved.

Except where noted, no material within the RenalWEB web sites can be copied, duplicated, or reproduced in any form without written consent from RenalWEB.